Devices › Device types
FDA product code FAD · class 2 · Gastroenterology, Urology
Stent, ureteral: medical device reports filed with FDA
5,909 reports carry this product code, 1993–2026; 22 brands with a page.
- 5,909
- reports with this product code
- 0% of all MAUDE reports
- 616
- reports, 12 months to August 2026
- 652 in the 12 months before
- 70.6%
- classified as malfunction
- 62.3% across all reports
- 0.2%
- classified as death, as reported
- 0.9% across all reports
Product code FAD is FDA's classification for "Stent, ureteral" (gastroenterology, Urology panel), a class 2 device. 5,909 medical device reports carry this product code, 0% of the MAUDE database, from September 1993 to August 2026.
616 reports arrived in the 12 months to August 2026, close to the 652 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (70.6%), injury (28.5%) and other (0.5%). 22 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Polaris? Ultra | 478 | 49 | 0% | 83.1% |
| Bard InLay Optima Ureteral Stent | 394 | 44 | 0% | 79.2% |
| Bard InLay Ureteral Stent with HydroGlide Guidewire | 342 | 17 | 0% | 86.5% |
| Percuflex Plus | 301 | 50 | 0.4% | 67.2% |
| Resonance Stent Set | 256 | 16 | 1.2% | 21.1% |
| Bard InLay Ureteral Stent | 232 | 25 | 0% | 69.8% |
| Filiform Double Pigtail Ureteral Stent Set | 225 | 38 | 0.4% | 81.1% |
| Bard InLay Optima Ureteral Stent with HydroGlide Guidewire | 220 | 14 | 0% | 88.6% |
| Universa Soft Ureteral Stent Set | 204 | 14 | 0% | 73.7% |
| Universa Firm Ureteral Stent Set | 203 | 12 | 0% | 61.1% |
| Contour | 157 | 38 | 0% | 85.3% |
| Polaris? Loop | 154 | 25 | 0.6% | 93.5% |
| Flexima? | 20 | 10 | 0.4% | 75.5% |
| Boston Scientific | 4 | 5 | 3.3% | 55% |
| Cotton-Leung Biliary Stent | 3 | 20 | 1.1% | 55.7% |
| Cook | 2 | 6 | 2.2% | 45% |
| Bard | 1 | 2 | 1.8% | 31.1% |
| Bardex Foley Catheter Silicone Coated | 1 | 306 | 0.1% | 93.9% |
| Evolution Biliary Controlled-Release Stent - Fully Covered | 1 | 99 | 0.2% | 83.7% |
| Evolution Duodenal Controlled-Release Stent - Uncovered | 1 | 5 | 0.5% | 52.7% |
| Olympus | 1 | 9 | 2.5% | 69.7% |
| Zimmon Pancreatic Stent | 1 | 6 | 0% | 85.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| C R Bard Covington -1018233 | 1,393 | 23.6% |
| Cook | 667 | 11.3% |
| Boston Scientific - Costa Rica Coyol | 295 | 5% |
| Cook Ireland | 288 | 4.9% |
| Coloplast A/S | 197 | 3.3% |
| Productos Para El Cuidado De La Salud -9611590 | 60 | 1% |
| C R Bard | 43 | 0.7% |
| Boston Scientific - Costa Rica | 21 | 0.4% |
| Applied Medical | 15 | 0.3% |
| Applied Medical Resources | 14 | 0.2% |
| Teleflex Medical | 11 | 0.2% |
| Gyrus Acmi | 9 | 0.2% |
| Boston Scientific | 5 | 0.1% |
| American Medical Systems | 4 | 0.1% |
| Angiomed & Medizintechnik Kg | 4 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Breakthe device broke | 1,427 | 24.1% |
| Material fragmentation | 595 | 10.1% |
| Calcified | 472 | 8% |
| Difficult to removethe device was hard to remove | 404 | 6.8% |
| Material separation | 246 | 4.2% |
| Material split, cut or torn | 232 | 3.9% |
| Difficult to advance | 213 | 3.6% |
| Detachment of device or device componentpart of the device came off | 212 | 3.6% |
| Material deformation | 200 | 3.4% |
| Migrationthe device moved from where it was placed | 171 | 2.9% |
| Deformation due to compressive stress | 168 | 2.8% |
| Patient device interaction problem | 128 | 2.2% |
| Fracturea broken bone | 125 | 2.1% |
| Biocompatibility | 99 | 1.7% |
| Detachment of device component | 97 | 1.6% |
| Migration or expulsion of device | 94 | 1.6% |
| Replace | 87 | 1.5% |
| Device damaged prior to usethe device was damaged before use | 74 | 1.3% |
| Torn material | 74 | 1.3% |
| Nonstandard device | 70 | 1.2% |
Questions about stent, ureteral reports
What is product code FAD?
FDA's classification code for "Stent, ureteral", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.
How many reports carry this code?
5,909 reports through August 2026, 616 of them in the latest 12 months.
Which brands appear most often?
Polaris? Ultra (478), Bard InLay Optima Ureteral Stent (394), Bard InLay Ureteral Stent with HydroGlide Guidewire (342), Percuflex Plus (301) and Resonance Stent Set (256). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.